Cargando…

An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses

Arthropod-borne chikungunya virus (CHIKV) infection can cause a debilitating arthritic disease in human. However, there are no specific antiviral drugs and effective licensed vaccines against CHIKV available for clinical use. Here, we developed an mRNA-lipid nanoparticle (mRNA-LNP) vaccine expressin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Ningning, Sun, Jin, Liu, Zhihua, Shu, Jiayi, Yan, Huimin, Kou, Zhihua, Wei, Yu, Jin, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wuhan Institute of Virology, Chinese Academy of Sciences 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170975/ https://www.ncbi.nlm.nih.gov/pubmed/35527225 http://dx.doi.org/10.1016/j.virs.2022.01.032

Ejemplares similares

A single nonsynonymous mutation on ZIKV E protein-coding sequences leads to markedly increased neurovirulence in vivo
por: Liu, Zhihua, et al.
Publicado: (2022)

A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice
por: Liu, Haitao, et al.
Publicado: (2017)

Development of Neutralization Assay Using an eGFP Chikungunya Virus
por: Deng, Cheng-Lin, et al.
Publicado: (2016)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

Viral Vaccines and CTL Response
por: Woolard, Stacie N., et al.
Publicado: (2010)

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein
por: Kam, Yiu-Wing, et al.
Publicado: (2012)

Recent progress on chikungunya virus research
por: An, Wenxi, et al.
Publicado: (2017)

Prostaglandin E(2) and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment
por: Miao, Jie, et al.
Publicado: (2017)

SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
por: Bartsch, Yannic C, et al.
Publicado: (2022)

Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes
por: Leviyang, Sivan, et al.
Publicado: (2015)

A Combined Adjuvant TF–Al Consisting of TFPR1 and Aluminum Hydroxide Augments Strong Humoral and Cellular Immune Responses in Both C57BL/6 and BALB/c Mice
por: Li, Qiao, et al.
Publicado: (2021)

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
por: August, Allison, et al.
Publicado: (2021)

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
por: Stenler, S., et al.
Publicado: (2017)

Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice
por: Ke, Qian, et al.
Publicado: (2022)

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
por: Andersen, Rikke Sick, et al.
Publicado: (2010)

Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response
por: Zvi, Anat, et al.
Publicado: (2011)

Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses
por: Metz, Stefan W., et al.
Publicado: (2016)

A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
por: Zhao, Gan, et al.
Publicado: (2023)

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)

Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660
por: Menon, VP, et al.
Publicado: (2012)

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
por: August, Allison, et al.
Publicado: (2022)

Expression and Evaluation of Chikungunya Virus E1 and E2 Envelope Proteins for Serodiagnosis of Chikungunya Virus Infection
por: Cho, Byungki, et al.
Publicado: (2008)

Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
por: Muthumani, Karuppiah, et al.
Publicado: (2016)

Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E Infection
por: Tripathy, Anuradha S., et al.
Publicado: (2012)

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
por: Foster, Jessica B., et al.
Publicado: (2019)

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
por: Pauthner, Matthias, et al.
Publicado: (2017)

Recombinant Full-Length Hepatitis C Virus E1E2 Dimer Elicits Pangenotypic Neutralizing Antibodies
por: Lin, Tianli, et al.
Publicado: (2022)

mRNA Vaccine Designing Using Chikungunya Virus E Glycoprotein through Immunoinformatics-Guided Approaches
por: Jaan, Samavia, et al.
Publicado: (2022)

Adenovirus-Vectored African Swine Fever Virus pp220 Induces Robust Antibody, IFN-γ, and CTL Responses in Pigs
por: Zajac, Michelle D., et al.
Publicado: (2022)

Cross-clade CTL recognitions for clade B and A/E viruses in A/E virus-infected Japanese individuals
por: Watanabe, K, et al.
Publicado: (2012)

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
por: Gagne, Matthew, et al.
Publicado: (2022)

Host Immune Response to Mosquito-Transmitted Chikungunya Virus Differs from That Elicited by Needle Inoculated Virus
por: Thangamani, Saravanan, et al.
Publicado: (2010)

Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection
por: Liu, Yi, et al.
Publicado: (2011)

Characterization of an Effective CTL Response against HIV and SIV Infections
por: Genescà, Meritxell
Publicado: (2011)

Strategies for Enhancing Vaccine-Induced CTL Antitumor Immune Responses
por: Yong, Xin, et al.
Publicado: (2012)

Stability Analysis of an Improved HBV Model with CTL Immune Response
por: Khabouze, Mostafa, et al.
Publicado: (2014)

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
por: Conforti, Antonella, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
por: Mudd, Philip A., et al.
Publicado: (2022)

Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes
Publicado: (1992)

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
por: Sun, Wenqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_80hjn8d1de4236jj15o6khjp8t